US EditionPublished • loading... • Updated
Dr. Reddy’s launches first-to-market OTC generic of extra-strength Pataday in U.S.
Summary by CDR – Chain Drug Review
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Dr. Reddy’s launches first-to-market OTC generic of extra-strength Pataday in U.S.
HYDERABAD, India, and PRINCETON, N.J. — Dr. Reddy’s Laboratories Ltd. has announced the launch of Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC), the first to market in the U.S. as a generic equivalent of Extra-Strength Pataday Once-Daily Relief, following FDA approval.The antihistamine eye drop is designed for temporary relief of itchy eyes caused by allergens like pollen, ragweed, grass, animal hair, and dander. The product come…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
